Videos de Experimentos Relacionados

Nuevas células de células viejas.

N Scolding¹

¹Institute of Clinical Neurosciences, University of Bristol, Frenchay Hospital, UK. N.J.Scolding@bristol.ac.uk

Lancet (London, England)

|February 24, 2001

Resumen

No abstract available in PubMed .

Palabras clave:

Investigaciones biomédicas y conductuales.Genética y reproducción.Enfoque jurídico El enfoque jurídico.

Videos de Conceptos Relacionados

También podría leer

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Journal of neurology·2021

Same author

Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.

Neuropathology and applied neurobiology·2016

Same author

Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2013

Same author

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.

Neurology·2011

Same author

The relationship between relapse, impairment and disability in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2011

Same author

Adult stem cells and multiple sclerosis.

Cell proliferation·2011

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

Ver todos los artículos relacionados

Videos de Experimentos Relacionados

Nuevas células de células viejas.

Videos de Conceptos Relacionados

Artículos Relacionados

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.

Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.

The relationship between relapse, impairment and disability in multiple sclerosis.

Adult stem cells and multiple sclerosis.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Videos de Experimentos Relacionados

Nuevas células de células viejas.

Videos de Conceptos Relacionados

Artículos Relacionados

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.

Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.

The relationship between relapse, impairment and disability in multiple sclerosis.

Adult stem cells and multiple sclerosis.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.